jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Sept. 22, 2025

Sept. 22, 2025

jRCT1030250383

Evaluation and development of comprehensive support and verification of effects of mood disorders in the acute phase centered on cognitive function

Evaluation and development of comprehensive support and verification of effects of mood disorders in the acute phase centered on cognitive function

Inamoto Atsuko

Northern Yokohama Hospital Showa University School of medicine

35-1,Chigasaki-chuo,Tsuzuki-ku ,Yokohama,Kanagawa

+81-45-949-7000

atsuko2@med.showa-u.ac.jp

Inamoto Atsuko

Northern Yokohama Hospital Showa University School of medicine

35-1,Chigasaki-chuo,Tsuzuki-ku ,Yokohama,Kanagawa

+81-45-949-7000

atsuko2@med.showa-u.ac.jp

Recruiting

Aug. 31, 2022

Aug. 31, 2022
80

Interventional

non-randomized controlled trial

open(masking not used)

no treatment control/standard of care control

parallel assignment

treatment purpose

(1) Patients who are hospitalized at the Mental Care Center, Yokohama City Northern Hospital, Showa University, and meet the diagnostic criteria for bipolar disorder or depression of ICD10
(2) Patients between 18 and 75 years of age at the time of obtaining consent
(3) Patients who have obtained written consent from the person concerned regarding participation in this research

Patients with unstable psychiatric symptoms

18age old over
75age old not

mood disorders

We will implement a psychological education program centered on improving cognitive impairment. From August 2021, we will use a group psychotherapy program using a complete workbook that contains elements of disease education and cognitive behavior therapy that are effective in previous research in west 2 wards. (Once a week: 1 hour: Tried in multiple occupations such as doctors, mental health workers, nurses, psychologists, occupational therapists, etc.) 6 times in total

psychological education program

The amount of changes before and after intervention in neuropsychological data (execution function, linguistic memory, narrative memory, working memory, processing speed, linguistic fluency, social cognition, attention)

Background survey: Gender, age, family structure, employment information, etc.
Clinical data: untreated period, disease period, past hospitalizations, number of days of community living, state drug information of medical welfare resources, etc.
Clinical indicators: General function evaluation (GAF), cognitive function question assessment (SCoRS-J), depression self-evaluation scale (SDS), Hamilton Depression Evaluation Scale (HAM-D) intelligence test (JART) recovery evaluation (RAS), solution construction scale (SBI-J), etc.

none
Ethics Committee on Human Research, etc. at Showa University
1-5-8 Hatanodai Shinagawa-ku, Tokyo

+81-3-3784-8129

ura-ec@ofc.showa-u.ac.jp
Approval

June. 23, 2022

Yes

none